Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.

Researchers detect genetic traces of hepatitis E viruses in wastewater

Researchers have identified genetic traces of hepatitis E viruses in almost 73 percent of wastewater samples from North-Rhine Westphalia.

January 31, 2024

Clinical trial starts slowed to below pre-pandemic levels last year, IQVIA analysis finds

Biopharma R&D spending rebounded in 2023, up $11 billion from 2022 following a steep post-pandemic decline. But the number of new clinical trial starts slowed

February 23, 2024

Invisible in the data: Broad ‘Asian American’ category obscures health disparities

They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population.

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.